Appropriateness of care: Deep venous procedures.

In the past decade, technologies to treat venous pathologies have increased dramatically, to the benefit of an often underserved and overlooked population of patients with venous disease. However, given the rapid release of various technologies, including venous-dedicated stents and thrombectomy devices across varied venous pathologies, evidence-based guidelines have been slow to develop. When discussing appropriateness of care, one needs to consider optimal patient selection, technical approach, medical management, and surveillance protocols, to name a few. All of which, in the venous space, are currently widely varied in practice. The future of deep venous work is limitless, but multicenter, randomized controlled trials are needed to optimally treat patients with venous disease.
Competing Interests: Declaration of competing interest Karem C. Harth discloses the following: consultant for Boston Scientific, Medtronic, Inari, Philips, and Inquis; speakers bureau for Cook and GE; and advisory board for MedVasc. Misaki M. Kiguchi discloses the following: speakers bureau for Medtronic and Boston Scientific.
(Copyright © 2024 The Author(s). Published by Elsevier Inc. All rights reserved.)